BioSpace News Archive

Phase 1 clinical program for PXL770 was observed to have a favorable pharmacokinetic, tolerability and safety profile

All doses were safe and well-tolerated

-Due to large backlog of applications, the Notified Body, LNE/G-MED, now expects completion of the process around year’s end

The event features renowned experts from Europe and the United States

Hackensack University Medical Center, a center for excellence in advanced robotic surgery, is the first and only hospital in New Jersey to have access to this groundbreaking technology

Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, has announced the expansion of its integrated care recovery and medical services with the launch of the company’s 21st clinic. The Madisonville Spero Health Center, located at 436 N. Main St., opened October 1 to start seeing new patients.

Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases (ILD).

A study from the University of Minnesota Combat Casualty Training Consortium shows no significant differences between the use of live tissue models and synthetic training models in the learners’ stress level.

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Tradjenta® on cardiovascular safety and kidney outcomes in adults with type 2 diabetes at high risk for heart and/or kidney disease.

Disruption of the refill of patients’ regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control and potentially lead to an increased rate of costly exacerbations and hospitalizations.